Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SNOAthis companySonoma Pharmaceuticals, Inc.	$1.15	-1.13×	1.16×	0.18×	-0.87×	-8313.3%	38.0%	-12.6%	-16.3%	-102.6%	-24.1%	-115.0%	0.27×	0.67×	0×	2.5×	0.0%	4	-13.67	2	C+
BFRIBiofrontera Inc.	$0.84	-0.55×	0.55×	0.14×	-0.61×	-3679.1%	78.7%	-21.9%	-25.3%	-100.5%	-53.8%	-230.5%	0.59×	0.03×	-20.24×	1.52×	0.0%	2	-6.17	1	C-
QNRXQuoin Pharmaceuticals, Ltd.	$3.71	-1.36×	1.65×	0×	241.74×	63270.6%	0.0%	0.0%	0.0%	-120.5%	-109.7%	-62.6%	0×	243.12×	0×	3.61×	0.0%	1	-13.64	2	C+
TCRTAlaunos Therapeutics, Inc.	$1.76	-1.47×	2.92×	1,258.64×	-1.18×	-81.2%	-27160.0%	-84500.0%	-83520.0%	-194.0%	-196.2%	-47.1%	0×	0.33×	0×	2.45×	0.0%	1	-860.38	1	C-
YCBDcbdMD, Inc.	$0.40	-1.11×	0.67×	0.25×	-3,187.39×	-66400.6%	62.4%	-11.3%	-10.6%	-28.2%	-0.3%	-33.6%	107.7×	-3,167.52×	0×	2.05×	0.0%	1	-17.56	2	C
Peer median	—	-1.23×	1.16×	0.2×	-0.89×	-1880.2%	31.2%	-16.6%	-17.9%	-110.5%	-81.8%	-54.9%	0.29×	0.18×	0×	2.25×	0.0%	1	-15.6	2	—